Effect of atorvastatin on muscle tissues of dermatomyositis and antisynthetase syndrome patients with dyslipidemia
ConclusionAtorvastatin did not promote significant changes in the expression of genes related to mitochondrial, oxidative, insulin, lipid, and fibrogenic pathways in the muscle tissues of DM and ASS patients with dyslipidemia. Atorvastatin did not also promote histological and histochemical changes in muscle tissues. Our results reinforce the safety of the administration of atorvastatin to treat dyslipidemia in patients with DM and ASS.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Isabela Bruna Pires Borges,
Sueli Mieko Oba ‐Shinjo,
Antonio Marcondes Lerario,
Suely Kazue Nagahashi Marie,
Samuel Katsuyuki Shinjo Tags: ORIGINAL ARTICLE Source Type: research
More News: Atorvastatin Calcium | Dermatology | Dermatomyositis | Genetics | Insulin | Lipitor | Mitochondrial Disease | Rheumatology | Statin Therapy | Study | Zivast